☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search category
Search here
Search here
Subscribe Now
Ocular Itching
Ocular Therapeutix Reports sNDA Submission of Dextenza (dexamethasone ophthalmic insert) to the US FDA for Ocular Itching
December 23, 2020
Bausch + Lomb Licenses US Commercial Rights for Eton Pharmaceuticals' EM-100 to Treat Ocular Itching
February 20, 2019
Load more...
Back to Home
